Masimo Announces Noninvasive Continuous Hemoglobin Monitoring (SpHb ® ) for CE Marking in Neonatal Indications

9 August 2019

Masimo today announced that continuous noninvasive hemoglobin monitoring SpHb ® for neonatal and infant patients (<3 kg) CE mark . With this approval, patients of all ages in the CE marked c